Equillium Inc (NASDAQ: EQ)’s stock price has gone decline by -2.29 in comparison to its previous close of 0.65, however, the company has experienced a 0.96% increase in its stock price over the last five trading days. businesswire.com reported 2024-11-13 that LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for the third quarter 2024 and provided corporate and clinical updates. “At the end of October we announced that our partnership with Ono Pharmaceutical had ended following substantial non-dilutive financing that has fully fund.
Is It Worth Investing in Equillium Inc (NASDAQ: EQ) Right Now?
Company’s 36-month beta value is 1.79.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EQ is 17.43M, and currently, short sellers hold a 0.45% ratio of that floaft. The average trading volume of EQ on December 27, 2024 was 172.51K shares.
EQ’s Market Performance
The stock of Equillium Inc (EQ) has seen a 0.96% increase in the past week, with a -14.73% drop in the past month, and a -20.13% fall in the past quarter. The volatility ratio for the week is 9.11%, and the volatility levels for the past 30 days are at 7.91% for EQ. The simple moving average for the past 20 days is -7.43% for EQ’s stock, with a -43.79% simple moving average for the past 200 days.
Analysts’ Opinion of EQ
Many brokerage firms have already submitted their reports for EQ stocks, with Stifel repeating the rating for EQ by listing it as a “Buy.” The predicted price for EQ in the upcoming period, according to Stifel is $12 based on the research report published on October 29, 2021 of the previous year 2021.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see EQ reach a price target of $14. The rating they have provided for EQ stocks is “Overweight” according to the report published on September 15th, 2021.
H.C. Wainwright gave a rating of “Buy” to EQ, setting the target price at $24 in the report published on July 14th of the previous year.
EQ Trading at -23.06% from the 50-Day Moving Average
After a stumble in the market that brought EQ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.58% of loss for the given period.
Volatility was left at 7.91%, however, over the last 30 days, the volatility rate increased by 9.11%, as shares sank -19.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.55% lower at present.
During the last 5 trading sessions, EQ rose by +0.96%, which changed the moving average for the period of 200-days by -75.06% in comparison to the 20-day moving average, which settled at $0.6816. In addition, Equillium Inc saw -12.72% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EQ starting from Keyes Jason A, who sale 10,000 shares at the price of $0.70 back on Nov 14 ’24. After this action, Keyes Jason A now owns 47,720 shares of Equillium Inc, valued at $7,000 using the latest closing price.
THE KEYES TRUST U/A DTD 09/10/, the Officer of Equillium Inc, proposed sale 20,000 shares at $0.78 during a trade that took place back on Nov 14 ’24, which means that THE KEYES TRUST U/A DTD 09/10/ is holding shares at $15,608 based on the most recent closing price.
Stock Fundamentals for EQ
Current profitability levels for the company are sitting at:
- -0.15 for the present operating margin
- 1.0 for the gross margin
The net margin for Equillium Inc stands at -0.1. The total capital return value is set at -0.29. Equity return is now at value -19.52, with -10.29 for asset returns.
Currently, EBITDA for the company is -12.14 million with net debt to EBITDA at 2.89. When we switch over and look at the enterprise to sales, we see a ratio of 0.16. The receivables turnover for the company is 9.17for trailing twelve months and the total asset turnover is 1.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.04.
Conclusion
In a nutshell, Equillium Inc (EQ) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
